Tesorx
Menlo Park, US · Founded 2010 · 1 known investors
Find your way into Tesorx
4 people in our graph share verified history with the Tesorx team — schools, employers, funds. One of them is your warm intro.
Megan Kotrappaunlockedknows Ramachandran Thirucote · together at Tesorx (overlapped)
×3knows the team · via Massachusetts College of Pharmacy and Health Sciences
TesoRx is a clinical-stage pharmaceutical company developing new therapies based on a proprietary drug delivery platform, focused on conditions with unmet needs and limited or sub-optimal treatment options.
Founders & leadership
Tesorx was founded in 2010 by Guru Betageri.
GB
Guru BetageriManager
WA
Willem A RobbertsChief Financial Officer and Manager
RT
Ramachandran ThirucoteinFounding Chairman & Chief Executive Officer
Investors · 1
Reported raises · per SEC filings
Form D private placements$3M disclosed across 3 rounds · 2014–2019
▶$289KraisedMay 2019 · 2 investors · PharmaceuticalsRule 506(b)
▶$289KraisedMay 2019 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Willem A RobbertsExecutive Officer, Director
- Ramachandran ThirucoteExecutive Officer, Director
- Offering amount
- $5.2M
- Amount sold
- $289K
- First sale
- Apr 2019
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$697.5KraisedJul 2016 · 8 investors · PharmaceuticalsRule 506(b)
▶$697.5KraisedJul 2016 · 8 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Guru BetageriDirector
- Willem A RobbertsExecutive Officer, Director
- Ramachandran ThirucoteExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $697.5K
- First sale
- Jul 2016
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$2MraisedMay 2014 · 3 investors · PharmaceuticalsRule 506(b)
▶$2MraisedMay 2014 · 3 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Ramachandran ThirucoteExecutive Officer, Director
- Guru BetageriDirector
- Willem A RobbertsExecutive Officer, Director
- Offering amount
- $10.1M
- Amount sold
- $2M
- First sale
- May 2014
- Incorporated
- Limited Liability Company, Delaware, 2010
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlap
Tarsus Pharmaceuticals5 shared keywordsTarsus is a biopharmaceutical company focused on developing and delivering medicines that target the root cause of serious diseases with high unmet need, including eye conditions. Its treatment areas include Demodex blepharitis, and it works closely with eye care professionals and patients.
Robinhood5 shared keywordsRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
AltaThera Pharmaceuticals5 shared keywordsAltaThera develops intravenous antiarrhythmic therapies for treating cardiac conditions including atrial fibrillation and ventricular tachycardia. The company's lead product, Sotalol IV, enables faster patient assessment and potential outpatient discharge compared to oral alternatives.
Companies competing with Tesorx for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Tesorx do?
- TesoRx is a clinical-stage pharmaceutical company developing new therapies based on a proprietary drug delivery platform, focused on conditions with unmet needs and limited or sub-optimal treatment options.
- Who founded Tesorx?
- Tesorx was founded by Guru Betageri in 2010.
- Who are Tesorx's investors?
- Tesorx's investors include Keiretsu Forum.
- How much funding has Tesorx raised?
- Tesorx has disclosed $3M raised across 3 rounds.
- Where is Tesorx headquartered?
- Tesorx is headquartered in Menlo Park, US.